AMH Levels by Age: What's Normal in Your 20s, 30s, and 40s

By Dr. Shweta Agarwal, MBBS, DGO Medically reviewed by Dr. Shweta Agarwal, MBBS, DGO Last updated: June 2026

Information on this page is educational and does not replace a medical consultation. Outcomes depend on individual clinical factors.

Aansh Hospital & IVF Center is a government-registered Level-2 ART clinic (Reg. No. MH/AC/2024/15441/L2/Chandrapur/132), part of a growing chain of fertility centres across Vidarbha and northern Telangana, with our headquarters and in-house embryology lab in Chandrapur. You can verify our government ART registration directly on the National ART & Surrogacy Registry.

When a patient sits across from me holding an AMH result, one of the first questions they ask is: "Is this normal?" The answer is almost always: "That depends on your age — and on which laboratory platform your test was run on."

This post is designed for that moment. It explains why "normal" AMH is age-dependent, presents a general age-band interpretation guide without universal numeric cutoffs (because assay variation is real and consequential), and covers the three things patients need to understand before interpreting any number: AMH measures egg quantity not quality; age-relative interpretation is essential; and high AMH from PCOS does not mean better fertility.

Marathi-speaking patients often ask about वय प्रमाणे AMH पातळी — "AMH levels by age" — and this page answers precisely that, with the same careful approach the sibling explainer What Is AMH? What a Low AMH Level Means for Fertility uses.

Why does AMH decline with age?

AMH is produced by granulosa cells in small antral and pre-antral follicles in the ovaries. As women age, the total pool of remaining follicles — the ovarian reserve — naturally decreases. Fewer follicles means fewer AMH-producing cells, and therefore a lower circulating AMH level.

This decline is not sudden. It begins in the mid-to-late twenties and accelerates through the thirties and into the forties. Because the decline is gradual and continuous, any single "normal" cutoff that ignores age is clinically misleading. A woman in her early twenties with an AMH at the lower end of what would be expected for a woman in her early forties does not have a "normal for her age" result — she has a result that suggests faster-than-expected reserve decline, which is clinically meaningful information.

This age-relative interpretation is the central reason published reference ranges present values by decade or five-year age band, not as a single population-wide number.

What is an AMH age-band reference table — and why are the numbers assay-specific?

Published AMH reference ranges are structured to reflect the pattern of AMH decline with age and are consistent with the approach used in the sibling post What Is AMH?.

AMH values differ materially between assays, including the Beckman Coulter Gen II assay and automated platforms such as Elecsys (Roche). ASRM cautions that ovarian reserve test values require contextual interpretation and are not standalone fertility predictions (per ASRM Committee Opinion, 2020). Publishing a single "normal AMH by age" number without specifying the assay platform and source would give patients a false sense of precision.

Caption: AMH values vary between assay platforms; the Beckman Coulter Gen II assay and the Elecsys (Roche) automated platform can produce different numerical results for the same sample. Any AMH result must be interpreted by a clinician together with your age, antral follicle count (AFC), and the assay platform your laboratory used. A laboratory's platform-specific reference interval is not an optimal target and is not a treatment cutoff. Do not make treatment decisions based on a table alone (per ASRM Committee Opinion, 2020).

What does "age-relative" mean in practice?

The same AMH number carries a different clinical meaning depending on your age. This is best illustrated concretely.

A result that falls at the lower end of the 40–44 year age band is, by definition, age-expected for a 43-year-old. For a 27-year-old, that same result sits far below what would be expected — it would indicate faster-than-expected reserve decline and would be clinically important to investigate and discuss. Conversely, a result in the middle of the 30–34 year range is entirely unremarkable for a 32-year-old, but if the same numerical result were the AMH of a 24-year-old, it might fall below the lower end of what is expected for that younger age band.

This is why I interpret AMH alongside the patient's age on every result, not just against a single reference value. The age band contextualises the number. A number without its age context is clinical information that is difficult to act on properly.

The other essential companion to AMH is the antral follicle count (AFC) — the direct ultrasound count of visible small follicles. When AMH and AFC are consistent with each other, the interpretation of reserve is more reliable. When they diverge, it prompts further investigation and often a repeat test. AMH and ovarian reserve testing at Aansh covers how these two markers are used together.

Does AMH measure egg quality or only egg quantity?

AMH measures ovarian reserve — egg quantity (the remaining pool of follicles available). It does not measure egg quality.

This distinction is covered in detail in the sibling post What Is AMH?, and it bears repeating here because it is the most important caveat when reading any AMH result. Egg quality — specifically the chromosomal integrity of individual eggs (whether they are euploid or aneuploid) — is primarily determined by age, not by the size of the ovarian reserve.

A 28-year-old with a low AMH for her age has a reduced pool of follicles to draw on in an IVF stimulation cycle, but the eggs she does have available are likely to be chromosomally healthy because she is 28. A 43-year-old with a high AMH has a larger pool available but age-related chromosomal changes affect her eggs at the rate expected for her age group — her high AMH does not protect egg quality.

AMH is a planning tool: it helps predict ovarian response to stimulation, guides protocol selection, and informs how many eggs are likely to be retrieved per cycle. It does not predict whether those eggs will be chromosomally competent, whether embryos will implant, or whether natural conception is possible. Those questions are answered by different assessments and are primarily age-driven. For how AMH and age interact in IVF specifically, see IVF Success and Age: Realistic Expectations.

Can AMH predict natural conception?

No — and this is one of the most clinically important things to understand about AMH.

Research consistently shows that AMH is a poor predictor of natural conception in the general population. Women with low AMH for their age conceive naturally. AMH tells us about the reserve available for ovarian stimulation in an assisted conception context; it does not function as a reliable test of whether spontaneous pregnancy is possible.

This matters because many patients come to a consultation after receiving a low AMH result elsewhere and having concluded — incorrectly — that they cannot conceive without medical intervention, or cannot conceive at all. A low AMH for age is meaningful clinical information: it may prompt a discussion about not delaying investigation, about the role of egg freezing if a future pregnancy is planned, and about what an IVF protocol might look like. It does not mean natural conception is ruled out.

AMH is a predictor of ovarian response to stimulation — a planning marker for assisted reproduction — not a fertility test in the sense of predicting natural pregnancy.

What does high AMH indicate — does it mean better fertility?

Not necessarily, and in a significant subset of women, a high AMH result is a sign that requires careful interpretation rather than reassurance.

The most important clinical context for elevated AMH is polycystic ovary syndrome (PCOS). Women with PCOS typically have a substantially higher AMH than expected for their age because their ovaries contain a large number of small antral follicles — the characteristic architecture of PCOS. More follicles means more AMH-producing cells and a higher reading.

This does not mean PCOS-associated high AMH confers better egg quality or greater fertility. For women with PCOS pursuing IVF, a high AMH signals the need for carefully adjusted stimulation protocols: too-aggressive stimulation in a high-AMH responder carries a risk of ovarian hyperstimulation syndrome (OHSS), a potentially serious complication. See PCOS for a detailed overview of what PCOS means for fertility management.

Outside of PCOS, a high AMH for age does represent a larger available follicle pool, which is relevant for IVF planning in the sense that more eggs are likely to be retrieved. But "more eggs available" is not the same as "better pregnancy outcomes" — those depend primarily on egg quality, which is age-driven.

What does a result below the age-band range suggest?

A result that falls below the general range for your age band — once verified on the correct assay platform — suggests faster-than-expected decline in ovarian reserve for that age group. This is sometimes referred to as diminished ovarian reserve (DOR). It is a clinical finding that warrants a full discussion, not a closed door.

The practical implications depend on the degree of decline, your age, and your fertility goals:

Discuss your reserve picture with a clinician. A single low AMH result is the start of a conversation, not a final verdict. Repeat testing, AFC on ultrasound, and a full clinical assessment together give a much more complete picture than any single result. See low AMH and diminished ovarian reserve for a detailed clinical overview.

Consider not delaying investigation. If your reserve is declining faster than expected, earlier investigation means more options are available. This is not about fear or urgency — it is about timing. More eggs are available sooner, and intervention options including egg freezing can be considered while the reserve is at its current level.

Egg freezing is worth considering if pregnancy is planned for the future. Oocyte cryopreservation freezes eggs at their current chromosomal quality (primarily determined by your age at the time of freezing) and current quantity. If your AMH is lower than expected for your age and you are not yet ready for pregnancy, egg freezing may be worth discussing now rather than later. See a fertility assessment with Dr. Shweta Agarwal for an individualised evaluation.

IVF is not precluded by low AMH. Low AMH for age means fewer eggs per retrieval cycle and a protocol that needs to be carefully individualised. It does not mean IVF cannot work. The IVF treatment page outlines how protocols are tailored to reserve profile.

What units does AMH use?

AMH results can be reported in different units depending on the laboratory and the assay platform used. When comparing your result to a reference range, always confirm which unit the range is expressed in and whether it matches the unit on your report — the same numeral can mean very different things depending on the unit.

If you have a result and want to discuss it in your specific clinical context, bring the report to a fertility assessment at Aansh and we will clarify the interpretation with you.

When should AMH be tested, and does it need to be repeated?

The AMH blood test can be done on any day of the menstrual cycle — unlike FSH, which must be measured on days two to four. It requires a standard blood draw and results are typically available within one to two working days from an accredited laboratory.

When to test: AMH is typically included in an initial fertility assessment alongside AFC on ultrasound and baseline hormonal investigations (FSH, LH, oestradiol). It is relevant for any woman who is planning pregnancy and wants to understand her ovarian reserve, considering egg freezing, about to begin IVF, or has received a low AMH result elsewhere and wants a clinical discussion.

Does it need repeating? AMH is more stable across the cycle than FSH, but it is not completely static. Small fluctuations between tests on the same platform are normal and do not necessarily indicate change. A result that is unexpected — either lower than the age-band would suggest, or substantially changed from a previous test — warrants a repeat test on the same laboratory platform, alongside a fresh AFC, before treatment decisions are made.

Assay platform consistency matters. If you tested AMH at one laboratory and retest at a different laboratory using a different assay platform, the numerical result may differ even if your actual reserve is unchanged. When tracking AMH over time, consistency of platform is important. Ask your laboratory which assay platform they use and note it alongside each result.

If you have an existing AMH result from another laboratory and want to discuss what it means in your full clinical context, WhatsApp us or call +91 80056 85160 to arrange a consultation with Dr. Shweta Agarwal.